RAXTEMY

Welcome to the Brand page for “RAXTEMY”, which is offered here for Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (copd) including chronic bronchitis and/or emphysema; anti-inflammatories;.

Its status is currently believed to be active. Its class is unavailable. “RAXTEMY” is believed to be currently owned by “MYLAN PHARMACEUTICALS, INC.”

Owner:
MYLAN PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema; Anti-inflammatories;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT